Sandra Coleman
Family · Dallas, TXNPI 1003219700
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.3% of the total across 369 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 19.1% — the pattern of someone who eats at a lot of different presentations. Among family clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 369 payments — averaging $18.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Corium, LLC$818
- Validus Pharmaceuticals LLC$817
- Supernus Pharmaceuticals, Inc.$767
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$672
- Otsuka America Pharmaceutical, Inc.$299
- plus $2K from 18 others
What the payments were for
- Food & beverage$6,79099%
- Education$491%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 64 | $1,306 |
| Corium, LLC | 56 | $818 |
| Validus Pharmaceuticals LLC | 11 | $817 |
| Supernus Pharmaceuticals, Inc. | 85 | $767 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 30 | $672 |
| Otsuka America Pharmaceutical, Inc. | 17 | $299 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $288 |
| Ironshore Pharmaceuticals Inc. | 12 | $250 |
| Johnson & Johnson | 9 | $215 |
| Bausch Health US, LLC | 12 | $210 |
| Tris Pharma Inc | 8 | $180 |
| Sunovion Pharmaceuticals Inc. | 9 | $168 |
| Noven Therapeutics, LLC | 7 | $147 |
| Axsome Therapeutics, Inc. | 7 | $147 |
| Collegium Pharmaceutical, Inc. | 9 | $143 |
| Vertical Pharmaceuticals, LLC | 6 | $114 |
| Lundbeck LLC | 6 | $113 |
| Novo Nordisk | 2 | $59 |
| Vanda Pharmaceuticals Inc. | 1 | $28 |
| Idorsia Pharmaceuticals US Inc | 1 | $23 |
| Neos Therapeutics, LP | 1 | $22 |
| Biogen | 1 | $21 |
| E.r. Squibb & Sons, L.L.C. | 1 | $17 |
| Avion Pharmaceuticals | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,839 in reported general payments places this provider in the 95th percentile of 15,456 family providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trazodone Hcl | 16 | $71 |
Paid to pharmacies, not to this prescriber.
Other family in Dallas
- David WeirDallas$959K
- Sie ThomasDallas$197K
- Marcia HarrisDallas$156K
- Miles HortonDallas$72K
- Natasha SimmonsDallas$38K
- Robin BeachHouston$428K
- April LopezMcAllen$417K
- Sarah AguilarHouston$199K
- Anna CastroSan Antonio$184K
- Jill CampbellShenandoah$182K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.